Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer
Clinical trial NCT04296240 · UNKNOWN
Trial details
- NCT number
- NCT04296240
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2021-04-01
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.